Summary Background. Tension-type headache (TTH) is common primary headache typically bilateral, pressing or tightening in quality and of mild to moderate intensity, lasting minutes to days. The pain does not worsen with routine physical activity and is not associated with nausea, but photophobia or phonophobia may be present. TTH can be distinguished into two subtypes: infrequent and frequent. There is no specific coded treatment in pediatric TTH. Aim of study is evaluating efficacy and safety of Griffonia simplicifolia/Magnesium nutraceutical complex as prophylactic therapy in a pediatric sample with frequent episodic tension type headache (FETTH). Methods. A prophylactic treatment with the complex nutraceutical Griffonia simplicifolia/ Magnesium orally twice a day for 3 months was administered to 79 children (38 M, mean age 9,24 ± 2,07 years) affecting by FETTH, efficacy of the treatment was estimated by comparison of the frequency and intensity of attacks before and after such treatment. Results. At T0, the mean frequency per month was equal to 6,81 attacks (SD ± 1,98) and the T1 was 1,25 (SD ± 0,93) (F = 510,35, p < 0,001), with an average rate Delta percentage was 86,04 (SD ± 15,73) to T1. Conclusions. Therefore, the present study aims as a preliminary study on the effectiveness of this complex in the form of tension headache defined as frequent episodic.
RIASSUNTO Background. La cefalea tensiva è un’algia di tipo gravativo-costrittivo, di intensità medio moderata, frequentemente bilaterale, di durata variabile da pochi minuti a diversi giorni, talvolta associata a fotofobia o fonofobia, osmofobia la cefalea tensiva episodica è stata ulteriormente suddivisa in due sottotipi: infrequente e frequente. Non esistono terapie codificate per tale forma di cefalea pediatrica. Scopo dello studio è verificare l’efficacia e sicurezza di un composto nutraceutico a base di griffonia simplicifolia/magnesio nella terapia preventiva in una popolazione pediatrica di soggetti affetti da cefalea tensiva episodica di tipo frequente (FETTH). Metodi. 79 bambini (38 M, età media 9,24 ± 2,07 anni) affetti da FETTH sono stati sottoposti a un trattamento profilattico con il complesso nutraceutico griffonia simplicifolia/magnesio per via orale due volte al giorno per 3 mesi, l’efficacia del trattamento è stata stimata con il confronto della frequenza e intensità degli attacchi prima e dopo tale trattamento. Risultati. A T0, la frequenza media al mese era pari a 6,81 attacchi (SD ± 1,98) e al T1 era 1,25 (SD ± 0,93) (F = 510,35, p < 0,001), con una media frequenza percentuale delta era 86,04 (SD ± 15.73) a T1. Conclusioni. Pertanto il presente studio si propone come studio preliminare sulla efficacia di tale complesso nella forma di cefalea tensiva definita come episodica frequente.
Trattamento profilattico della Cefalea Tensiva Episodica Frequente in età evolutiva: efficacia del complesso nutraceutico Griffonia simplicifolia/Magnesio
Marco Carotenuto
Supervision
;Maria Rosaria BarillariMembro del Collaboration Group
;Umberto BarillariMembro del Collaboration Group
;Maria EspositoData Curation
2015
Abstract
Summary Background. Tension-type headache (TTH) is common primary headache typically bilateral, pressing or tightening in quality and of mild to moderate intensity, lasting minutes to days. The pain does not worsen with routine physical activity and is not associated with nausea, but photophobia or phonophobia may be present. TTH can be distinguished into two subtypes: infrequent and frequent. There is no specific coded treatment in pediatric TTH. Aim of study is evaluating efficacy and safety of Griffonia simplicifolia/Magnesium nutraceutical complex as prophylactic therapy in a pediatric sample with frequent episodic tension type headache (FETTH). Methods. A prophylactic treatment with the complex nutraceutical Griffonia simplicifolia/ Magnesium orally twice a day for 3 months was administered to 79 children (38 M, mean age 9,24 ± 2,07 years) affecting by FETTH, efficacy of the treatment was estimated by comparison of the frequency and intensity of attacks before and after such treatment. Results. At T0, the mean frequency per month was equal to 6,81 attacks (SD ± 1,98) and the T1 was 1,25 (SD ± 0,93) (F = 510,35, p < 0,001), with an average rate Delta percentage was 86,04 (SD ± 15,73) to T1. Conclusions. Therefore, the present study aims as a preliminary study on the effectiveness of this complex in the form of tension headache defined as frequent episodic.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.